{
  "main_header": {
    "sid": 1003129,
    "name": "Metropolis Healt",
    "stock_name": "Metropolis Healt",
    "full_name": "Metropolis Healthcare Ltd",
    "name_url": "stocks-analysis/metropolis-healt",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,577.70",
    "chg": 4.2,
    "chgp": "0.27%",
    "dir": 1,
    "prev_price": "1,573.50",
    "mcapval": "8,090.62 Cr",
    "mcap": "Mid Cap",
    "scripcode": 542650,
    "symbol": "METROPOLIS",
    "ind_name": "Hospital & Healthcare Services",
    "ind_code": 94,
    "isin": "INE112L01020",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:19 AM",
    "bse_nse_vol": "62.84 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/metropolis-healt-1003129-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Metropolis Healthcare Adjusts Valuation Amidst Challenging Performance and Competitive Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/metropolis-healthcares-valuation-grade-changes-from-expensive-to-fair-amid-price-decline-1670078",
        "imagepath": "",
        "date": "2025-04-02 08:02:56",
        "description": "Metropolis Healthcare has recently undergone a valuation adjustment, reflecting its current standing within the Hospital & Healthcare Services industry. The company’s price-to-earnings (PE) ratio stands at 51.38, while its price-to-book value is recorded at 6.61. Other key metrics include an EV to EBIT ratio of 36.53 and an EV to EBITDA ratio of 24.40, indicating its operational efficiency relative to its enterprise value.\n\nIn terms of return performance, Metropolis Healthcare has faced challenges, with a year-to-date return of -26.08%, contrasting sharply with the Sensex's decline of only -2.71% over the same period. Over a three-year horizon, the company has seen a return of -27.08%, while the Sensex has gained 28.25%. \n\nWhen compared to its peers, Metropolis Healthcare's valuation metrics appear more favorable, particularly against companies like Dr. Agarwal's Healthcare and Rainbow Children's Hospital, ..."
      },
      {
        "title": "Metropolis Healthcare Hits 52-Week Low Amid Broader Market Decline and Weak Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/metropolis-healthcare-hits-52-week-low-amid-broader-market-decline-1661754",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/MetropolisHealt_priceRelatedfactors_853933.png",
        "date": "2025-04-01 12:00:15",
        "description": "Metropolis Healthcare has reached a new 52-week low, continuing its recent struggles with a two-day loss and underperformance compared to its sector. The company's financial metrics show slow growth in net sales and operating profit, alongside declining profits and cash reserves, raising concerns about its valuation."
      },
      {
        "title": "Metropolis Healthcare Hits 52-Week Low Amid Ongoing Financial Struggles and Sector Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/metropolis-healthcare-stock-hits-52-week-low-amid-broader-market-decline-1661611",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/MetropolisHealt_priceRelatedfactors_853931.png",
        "date": "2025-04-01 12:00:14",
        "description": "Metropolis Healthcare has reached a new 52-week low, continuing a two-day decline. The stock is trading below all major moving averages and has underperformed its sector over the past year. Financial metrics indicate slow growth in sales and profits, despite a strong return on capital employed."
      },
      {
        "title": "Metropolis Healthcare Hits 52-Week Low Amid Sustained Downward Trend in Stock Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/metropolis-healthcare-hits-52-week-low-amid-continued-stock-decline-and-underperformance-1171429",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/MetropolisHealt_priceRelatedfactors_561666.png",
        "date": "2025-03-03 09:37:48",
        "description": "Metropolis Healthcare has reached a new 52-week low, reflecting a consistent decline over the past four days. The stock has underperformed its sector and is trading below key moving averages. Over the past year, it has recorded a notable decline, contrasting with the overall market performance."
      },
      {
        "title": "Metropolis Healthcare Faces Bearish Technical Trends Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/metropolis-healthcares-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-stock-decline-2-1128185",
        "imagepath": "",
        "date": "2025-02-27 08:01:28",
        "description": "Metropolis Healthcare, a midcap player in the Hospital & Healthcare Services industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1,662.65, down from a previous close of 1,682.90. Over the past year, Metropolis has experienced a stock return of -4.77%, contrasting with a 2.00% return from the Sensex, indicating a relative underperformance.\n\nThe technical summary reveals a bearish sentiment in various indicators. The MACD shows a bearish trend on a weekly basis, while the monthly outlook is mildly bearish. The Bollinger Bands also reflect a bearish stance, particularly on a monthly basis. Moving averages indicate a bearish trend, and the KST presents a mixed picture with a bearish weekly signal but a bullish monthly outlook. \n\nIn terms of price movement, the stock has seen a 52-week high of 2,306.85 and a low of 1,555.55, with today'..."
      },
      {
        "title": "Metropolis Healthcare Experiences Trend Reversal Amid Broader Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/metropolis-healthcare-stock-rises-5-16-after-four-days-of-decline-745700",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/MetropolisHealt_priceRelatedfactors_359135.png",
        "date": "2025-02-05 12:05:23",
        "description": "Metropolis Healthcare experienced a significant uptick in its stock performance, reversing a four-day decline. The stock outperformed its sector and the broader market, although it has faced challenges over the past month. Current moving averages indicate mixed trends in the short to long term."
      },
      {
        "title": "Metropolis Healthcare Experiences Trend Reversal Amid Broader Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/metropolis-healthcare-stock-rises-5-16-after-four-days-of-decline-2-760053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/MetropolisHealt_priceRelatedfactors_359135.png",
        "date": "2025-02-05 12:05:23",
        "description": "Metropolis Healthcare experienced a significant uptick in its stock performance, reversing a four-day decline. The stock outperformed its sector and the broader market, although it has faced challenges over the past month. Current moving averages indicate mixed trends in the short to long term."
      },
      {
        "title": "Metropolis Healthcare Reports Flat Q3 FY24-25 Results Amid Mixed Financial Indicators",
        "link": "https://www.marketsmojo.com/news/result-analysis/metropolis-healthcare-reports-flat-q3-fy24-25-results-with-declining-profit-metrics-746290",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/MetropolisHealt_quaterlyResult_352316.png",
        "date": "2025-02-04 21:03:31",
        "description": "Metropolis Healthcare's financial results for Q3 FY24-25 indicate a flat performance, with a notable decline in its evaluation score. The company maintains a low debt-equity ratio of 0.16 times and a strong debtor turnover ratio of 9.58 times, but faces challenges with decreased profit before and after tax and reduced cash reserves."
      },
      {
        "title": "Metropolis Healthcare Shows Short-Term Recovery Amid Long-Term Trading Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/metropolis-healthcare-stock-rises-5-24-despite-13-17-monthly-decline-384998",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/1/MetropolisHealt_priceRelatedfactors_280907.png",
        "date": "2025-01-29 15:20:29",
        "description": "Metropolis Healthcare saw a significant rebound on January 29, 2025, after three days of decline, outperforming its sector. However, it remains below key moving averages and has faced a 13.17% decline over the past month, contrasting with a smaller drop in the broader Sensex index."
      }
    ],
    "total": 63,
    "sid": "1003129",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/metropolis-healthcare-1003129"
  },
  "announcements": [
    {
      "caption": "Business Update For Q4FY25",
      "datetime": "05-Apr-2025",
      "details": "Business update for Q4FY25",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Mar-2025",
      "details": "Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "29-Mar-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dr Duru Sushil Shah & PACs",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Metropolis Healthcare Ltd has declared <strong>200%</strong> dividend, ex-date: 17 Nov 23",
          "dt": "2023-11-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Metropolis Healthcare Adjusts Valuation Amidst Challenging Performance and Competitive Landscape

2025-04-02 08:02:56

Metropolis Healthcare has recently undergone a valuation adjustment, reflecting its current standing within the Hospital & Healthcare Services industry. The company’s price-to-earnings (PE) ratio stands at 51.38, while its price-to-book value is recorded at 6.61. Other key metrics include an EV to EBIT ratio of 36.53 and an EV to EBITDA ratio of 24.40, indicating its operational efficiency relative to its enterprise value. In terms of return performance, Metropolis Healthcare has faced challenges, with a year-to-date return of -26.08%, contrasting sharply with the Sensex's decline of only -2.71% over the same period. Over a three-year horizon, the company has seen a return of -27.08%, while the Sensex has gained 28.25%. When compared to its peers, Metropolis Healthcare's valuation metrics appear more favorable, particularly against companies like Dr. Agarwal's Healthcare and Rainbow Children's Hospital, ...

Read More

Metropolis Healthcare Hits 52-Week Low Amid Broader Market Decline and Weak Financial Metrics

2025-04-01 12:00:15

Metropolis Healthcare has reached a new 52-week low, continuing its recent struggles with a two-day loss and underperformance compared to its sector. The company's financial metrics show slow growth in net sales and operating profit, alongside declining profits and cash reserves, raising concerns about its valuation.

Read More

Metropolis Healthcare Hits 52-Week Low Amid Ongoing Financial Struggles and Sector Underperformance

2025-04-01 12:00:14

Metropolis Healthcare has reached a new 52-week low, continuing a two-day decline. The stock is trading below all major moving averages and has underperformed its sector over the past year. Financial metrics indicate slow growth in sales and profits, despite a strong return on capital employed.

Read More

Metropolis Healthcare Hits 52-Week Low Amid Sustained Downward Trend in Stock Performance

2025-03-03 09:37:48

Metropolis Healthcare has reached a new 52-week low, reflecting a consistent decline over the past four days. The stock has underperformed its sector and is trading below key moving averages. Over the past year, it has recorded a notable decline, contrasting with the overall market performance.

Read More

Metropolis Healthcare Faces Bearish Technical Trends Amid Market Challenges

2025-02-27 08:01:28

Metropolis Healthcare, a midcap player in the Hospital & Healthcare Services industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1,662.65, down from a previous close of 1,682.90. Over the past year, Metropolis has experienced a stock return of -4.77%, contrasting with a 2.00% return from the Sensex, indicating a relative underperformance. The technical summary reveals a bearish sentiment in various indicators. The MACD shows a bearish trend on a weekly basis, while the monthly outlook is mildly bearish. The Bollinger Bands also reflect a bearish stance, particularly on a monthly basis. Moving averages indicate a bearish trend, and the KST presents a mixed picture with a bearish weekly signal but a bullish monthly outlook. In terms of price movement, the stock has seen a 52-week high of 2,306.85 and a low of 1,555.55, with today'...

Read More

Metropolis Healthcare Experiences Trend Reversal Amid Broader Market Challenges

2025-02-05 12:05:23

Metropolis Healthcare experienced a significant uptick in its stock performance, reversing a four-day decline. The stock outperformed its sector and the broader market, although it has faced challenges over the past month. Current moving averages indicate mixed trends in the short to long term.

Read More

Metropolis Healthcare Experiences Trend Reversal Amid Broader Market Challenges

2025-02-05 12:05:23

Metropolis Healthcare experienced a significant uptick in its stock performance, reversing a four-day decline. The stock outperformed its sector and the broader market, although it has faced challenges over the past month. Current moving averages indicate mixed trends in the short to long term.

Read More

Metropolis Healthcare Reports Flat Q3 FY24-25 Results Amid Mixed Financial Indicators

2025-02-04 21:03:31

Metropolis Healthcare's financial results for Q3 FY24-25 indicate a flat performance, with a notable decline in its evaluation score. The company maintains a low debt-equity ratio of 0.16 times and a strong debtor turnover ratio of 9.58 times, but faces challenges with decreased profit before and after tax and reduced cash reserves.

Read More

Metropolis Healthcare Shows Short-Term Recovery Amid Long-Term Trading Challenges

2025-01-29 15:20:29

Metropolis Healthcare saw a significant rebound on January 29, 2025, after three days of decline, outperforming its sector. However, it remains below key moving averages and has faced a 13.17% decline over the past month, contrasting with a smaller drop in the broader Sensex index.

Read More

View All News